NanoLuc® Binary Technology-based Assays for SARS-CoV-2 Research and Drug/Vaccine Development
SARS-CoV-2 is a newly emerged coronavirus responsible for the current COVID-19 pandemic. Understanding the biology and pathogenesis of
SARS-CoV-2 is critical to accomplish the challenging task of developing effective anti-viral treatments and vaccines.
In this webinar, we will introduce a selection of bioluminescent assays and molecular tools based on the versatile NanoLuc® Binary Technology (NanoBiT®). We will demonstrate how these assays allow for the investigation of various aspects of the SARS-CoV-2 life cycle and can be applied in the development of anti-viral drugs and vaccines.
You will learn:
• About the principle and advantages of the NanoLuc® Binary Technology
• How NanoBiT® supports the analysis of virus-host interactions
• How to study antiviral activities of therapeutic antibodies against
Wednesday, July 7th, 2021 at 10:00 am CEST